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(Correspondence should be addressed to J A Martinez; Email: jalfmtz@unav.es)AbstractAntioxidant-based treatments are emerging as an interesting approach to possibly counteract obesity fat accumulation
complications, since this is accompanied by an increased systemic oxidative stress. The aim of this study was to analyze
specific metabolic effects of vitamin C (VC) on epididymal primary rat adipocytes. Cells were isolated and incubated for
72 h in culture medium, in the absence or presence of 1.6 nM insulin, within a range of VC concentrations (5–1000 mM).
Glucose- and lipid-related variables as well as the secretion/expression patterns of several obesity-related genes were
assessed. It was observed that VC dose dependently inhibited glucose uptake and lactate production, and also reduced
glycerol release in both control and insulin-treated cells. Also, VC caused a dramatic concentration-dependent fall in
leptin secretion especially in insulin-stimulated cells. In addition, VC (200 mM) induced Cdkn1a and Casp8, partially
inhibited Irs3, and together with insulin drastically reducedGpdh (listed asGpd1 in the MGI database) gene expressions.
Finally, VC and insulin down-regulatory effects were observed on extracellular and intracellular reactive oxygen species
production respectively. In summary, this experimental assay describes a specific effect of VC in isolated rat adipocytes
on glucose and fat metabolism, and on the secretion/expression of important obesity-related proteins.Journal of Molecular Endocrinology (2010) 45, 33–43Introduction
Worldwide, obesity is emerging as one of the major
health threats (Powers et al. 2007). Indeed, it is well
known that an excessive body fat accumulation, which
defines this disease, could lead to several associated
clinical manifestations such as type 2 diabetes, meta-
bolic syndrome features, cardiovascular events, and
arthritis (Bray 2004). These effects are related to a white
adipose tissue (WAT) overgrowth and also to an
impaired production and secretion of endogenous
products by the enlarged adipocytes or the macro-
phages coexisting in the tissue (Bray 2004), which often
have pro-inflammatory properties (Fantuzzi 2005).
Actually, it has been reported that several inflammatory
products derived from this tissue, such as TNF-a, IL6,
MCP-1 (listed as CCL2 in the MGI database), and iNOS
(NOS2), correlate with increased body adiposity
(Ferrante 2007). In addition, it has been reported
that inflammatory-related pathways are activated in
obesity and insulin resistance states (Yuan et al. 2001,
Cai et al. 2005). Besides the secretion of these
pro-inflammatory cytokines, the adipose tissue pro-
duces other substances that also have important local
and systemic effects (Fantuzzi 2005). Among these
molecules, leptin, which is related to the control of food
intake and energy expenditure (Zhang et al. 1994), and
adiponectin, which is related to significant insulinJournal of Molecular Endocrinology (2010) 45, 33–43
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visfatin, which has been reported to have controversial
associations with insulin resistance and obesity, are
metabolically relevant (Fukuhara et al. 2005, Haider
et al. 2006, Varma et al. 2007).
On the other hand, in obesity, a mitochondrial
dysfunction and reactive oxygen species (ROS) over-
production as well as an association between oxidative
stress and insulin resistance have been observed
(Martinez 2006). In this sense, in obese patients
(Vincent & Taylor 2006) and in overweight animal
models (Furukawa et al. 2004, Milagro et al. 2006), an
elevated oxidative stress has been documented.
Furthermore, depletion of the antioxidant defenses
has also been described in obesity (Mutlu-Turkoglu et
al. 2003). This oxidative stress unbalanced status is
related to chronic inflammation and hyperleptinemia
(Vincent & Taylor 2006). Thus, induced monocyte
migration to the adipose tissue and high secretion levels
of some WAT-secreted adipokines are directly impli-
cated in the obesity-associated ROS overproduction.
This fact links the pathogenic secretion pattern of WAT
with an enhanced oxidative stress status (Moreno-A-
liaga et al. 2005).
The abilities of antioxidant vitamins include free
radical depletion, nitric oxide synthesis or release
control, ROS production inhibition, and the induction
of antioxidant enzymes (Flora 2007). In this context, itDOI: 10.1677/JME-09-0160
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acid or vitamin C (VC) is negatively associated with the
presence of several conditions such as hypertension,
gallbladder disease, stroke, cancers, and atherosclerosis
(Bsoul & Terezhalmy 2004), and also with the
occurrence of obesity (Canoy et al. 2005, Johnston
2005). Among the beneficial effects of ascorbic acid on
obesity-related mechanism, the modulation of adipo-
cyte lipolysis (Misekova et al. 1993, Hasegawa et al. 2002,
Senen et al. 2002, Garcia-Diaz et al. 2009), glucocorti-
coid release from adrenal glands (Doulas et al. 1987),
hyperglycemia improvement and glycosylation decrease
in obese diabetic mice (Abdel-Wahab et al. 2002), and
an inhibition of the inflammatory response (Carcamo
et al. 2002) have been described.
Taking all these findings into account, in this study,
an attempt to identify the potential relationships
between gene expression and secretion of WAT
adipokines as affected by VC treatment in rat primary
culture adipocytes was made. Moreover, this work
aimed to analyze whether this antioxidant treatment
has implications concerning the glucose and lipid
metabolism and in the oxidative stress status of rat
fat cells.Materials and methods
Materials
DMEM, 100! minimal essential medium (MEM)
non-essential amino acids, penicillin/streptomycin,
heat-inactivated fetal bovine serum (FBS), 10! MEM,
nystatin, Trizol Reagent, and M-MLV reverse transcrip-
tase were obtained from Invitrogen. BSA, HEPES,
insulin, and 2 0,7 0-dichlorofluorescein (DCFH) were all
obtained from Sigma–Aldrich Company. Collagen
(Purecol) was purchased from Nutacon (Leimuiden,
The Netherlands). Type I collagenase was supplied by
Worthington Biochemical Corporation (Lakewood, NJ,
USA), and VC by Panreac Quimica (Barcelona, Spain).
Glycerol-3-phosphate dehydrogenase (GPDH, listed as
GPD1 in the MGI database), glycerol kinase (GK, GYK),
ATP, and NAD were obtained from Roche Diagnostics.Animals
Eight-week-old male Wistar rats (G250 g weight) that
were supplied by the Center for Applied Pharmacobiol-
ogy Research (CIFA, Pamplona, Spain) were housed in
temperature-controlled rooms at 21–23 8C under a 12-h
light cycle (lights were switched off at 2000 h). The rats
(nZ7) were killed, and their epididymal WAT was
removed for adipocyte isolation. All the procedures
were performed according to the European National
and Institutional Guidelines of the Animal Care and
Use Committee at the University of Navarra.Journal of Molecular Endocrinology (2010) 45, 33–43Adipocyte isolation and culture
Primary cultures were performed according to proto-
cols described elsewhere (Lorente-Cebrian et al. 2009).
Epididymal WAT (3–4 g) of each rat (nZ7) was minced
using scissors in HEPES–phosphate buffer (pH 7.4;
containing 5 mM D-glucose, 2% BSA, 135 mM NaCl,
2.2 mM CaCl2.2H2O, 1.25 mM MgSO4.7H2O, 0.45 mM
KH2PO4, 2.17 mM Na2HPO4, and 10 mM HEPES).
WAT fragments were digested in the same buffer with
type I collagenase (1.25 mg/ml per 0.5 g tissue) at
37 8C with gentle shaking for 30 min. The resulting cell
suspension was diluted in the buffer, and then the
adipocytes were isolated from the undigested tissue by
filtration through a 400-mm nylon mesh and washed
three times with alternate centrifugations at 500 g. for
6 min. Isolated adipocytes were then resuspended in
DMEM supplemented with 1% FBS, 100 U/ml peni-
cillin and 100 mg/ml streptomycin, 100 U/ml nystatin,
and 1! MEM non-essential amino acids, followed by
incubation for 40 min at 37 8C in 5% CO2. The
resulting isolated adipocytes (150 ml of a 2:1 mix of
packed cells/culture medium) were then plated on
500 ml of a collagen matrix (pH 7, 7 parts collagen: 1
part 10! MEM) in six-well culture plates. After
40–50 min of incubation at 37 8C in 5% CO2, the
culture medium containing 0 or 1.6 nM insulin and
different concentrations (0, 5, 10, 50, 200, and
1000 mM) of VC was added. Cells were maintained in
an incubator at 37 8C in 5% CO2 up to 72 h. VC was
freshly added every day. Aliquots of the culture medium
were collected at the end of the experimental trial, and
conserved at K80 8C for further assays.Culture medium determinations
All the assays were performed on 72-h treatment
samples. Cell viability (nZ5) was measured using the
lactate dehydrogenase (LDH) Cytotoxicity Assay Kit
according to the manufacturer’s indications (Cayman
Chemical Company, Ann Arbor, MI, USA). LDH activity
(mU/ml) in the culture medium was used as an
indicator of cell membrane integrity, and thus as a
measurement of cell necrosis/apoptosis. Cell viability
was assayed at the end of the experimental period in
control and insulin/VC (200 mM)-treated cells. Glucose
and lactate concentrations in the medium were
measured using the HK-CP kit obtained from ABX
Diagnostic (Montpellier, France) and the L-lactate kit
obtained from Randox Laboratories (Crumlin, UK)
respectively using an automatized COBAS MIRA
equipment (Roche). The amount of released carbon
as lactate per amount of carbon taken up as glucose
over this time (glucose to lactate %) was calculated as
(lactate concentration/glucose concentration)!100.
Glycerol concentration in the medium, as a measurewww.endocrinology-journals.org
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colorimetric method (Campion & Martinez 2004).
Briefly, culture medium of each sample was incubated
with 25 mg/ml GPDH and 250 mU/ml GK in the
presence of 43.6 mM MgCl2, 200 mM glycine, 5.2%
hydrazine, 1.24 mM ATP, and 573 mM NAD for 40 min.
Finally, sample absorbance was measured at 340 nm.
Leptin secretion was determined using the Rat Leptin
ELISA kit obtained from Linco Research (St Charles,
MO, USA), adiponectin using the Mouse/Rat Adipo-
nectin ELISA kit obtained from B-Bridge International
(Mountain View, CA, USA), and visfatin using the
Visfatin EIA kit obtained from ALPCO Diagnostics
(Salem, NH, USA).Gene expression assays
Total RNA was isolated from isolated epididymal
adipocytes incubated with or without 1.6 nM insulin
and treated or not treated with 200 mM VC using Trizol
(Invitrogen) according to the manufacturer’s protocol.
Purified total RNA from adipocytes was then treated
with DNAse (DNAfree kit; Ambion Inc., Austin, TX,
USA), and used to generate cDNA with M-MLV
reverse transcriptase (Invitrogen). Relative real-time
PCR was performed on an ABI PRISM 7000 HT
Sequence Detection System (Applied Biosystems, Foster
City, CA, USA). Taqman probes for rat leptin, adipo-
nectin, visfatin, Gpdh, insulin receptor substrate 3 (Irs3),
cyclin-dependent kinase inhibitor 1A (Cdkn1a), caspase
8 (Casp8), Gapdh, and 18S rRNA were also supplied by
Applied Biosystems. All the expression levels of the
target genes studied were normalized by the two selected
internal controls, Gapdh and 18S, applying the GeNorm
software (http://medgen.ugent.be/~jvdesomp/genorm/;
Vandesompele et al. 2002).ROS determination
DCFH was used for intracellular and extracellular ROS
concentration measurements with a protocol described
elsewhere (Fu et al. 2008). Once inside the cell, this
molecule is cleaved by endogenous esterases and can
no longer pass out of the cell membrane. The
de-esterified product becomes a fluorescent compound
after oxidation by ROS (Brandt & Keston 1965). Briefly,
cells were incubated with 10 mM DCFH for 40 min at
37 8C in 5% CO2, frozen for at least 1 h atK80 8C, and
then lysed using 1000 ml lysis buffer (150 mM NaCl,
0.1% Triton, and 10 mM Tris). Finally, 200 ml of each
lysate were plated on a 96-well black plate (Labsystems,
Barcelona, Spain). For extracellular ROS determina-
tions, 300 ml of culture medium of each sample (from
1000 ml of total incubation volume) after the 72-h
treatment were also incubated with 10 mM DCFH forwww.endocrinology-journals.org40 min at 37 8C in 5% CO2, frozen for at least 1 h at
K80 8C, and then 200 ml from this incubation mix were
loaded on a 96-well black plate. Finally, fluorescence
intensity was measured using a POLARstar spectro-
fluorometer plate reader (BMG Labtechnologies,
Offenburg, Germany) at an excitation of 485 nm
wavelength and at an emission of 530 nm wavelength.Statistical analysis
Due to reduced sample size in some of the experi-
mental groups, non-parametric analyses were
performed. Thus, Kruskal–Wallis test was used followed
by Mann–Whitney U tests for further comparisons.
Results are shown using box and whisker plots
expressing median and interquartile range. For ROS
determinations, parametric analyses (two-way ANOVA)
were performed due to their normal distribution, which
was determined by the Shapiro–Wilk test, and equal
sample number among experimental groups. These
results were expressed by meanGS.E.M. A probability of
P!0.05 was set for determining significant differences.
All the analyses were performed using the GraphPad
Prism 4.0 software (GraphPad Software, San Diego, CA,
USA) and the SPSS 15.0 for Windows software (SPSS
Inc., Chicago, IL, USA).Results
Glucose and lipid metabolism
Initially, LDH cytotoxicity assay presented no statistical
differences among the experimental groups, indicating
that neither insulin nor VC induced necrosis/apoptosis
in rat epididymal adipocytes after the 72-h treatment at
the assayed doses (data not shown). Adipocytes treated
with VC exhibited lower glucose uptake than controls
(Fig. 1A). On the other hand, insulin induced a
marginally significant (PZ0.053) inducing effect on
the glucose uptake of the adipocytes. Specifically,
among the adipocytes without insulin treatment,
200 mM VC induced a significant decrease in the
glucose uptake compared with the controls (P!0.05).
Moreover, in adipocytes that were incubated with
insulin, the VC treatment induced a substantial and
concentration-dependent decrease in the glucose
uptake, with this reduction being statistically significant
with concentrations over 50 mM versus adipocytes
treated with insulin alone (P!0.05 for 50, and
P!0.01 for 200 and 1000 mM).
On the other hand, the lactate production of the
adipocytes was not significantly affected by the insulin
treatment (Fig. 1B), but increasing concentrations of
VC induced a lower production of this anaerobic
metabolite, which was statistically significant overJournal of Molecular Endocrinology (2010) 45, 33–43
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Figure 1 Effects of vitamin C (log (5–1000 mM)) in the absence
(white circles) or presence (black triangles) of 1.6 nM insulin on
(A) glucose uptake, (B) lactate production, and (C) glycerol
release in isolated rat adipocytes over 72 h in culture. Data (nR4,
median and interquartile range). aP!0.05 and bP!0.01 versus
control cells (with or without insulin treatment). PZ0.053, control
versus controlCinsulin cells. VC, vitamin C; Ins, insulin.
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D F GARCIA-DIAZ and others . Vitamin C effects on primary adipocytes36200 mM VC for both untreated (P!0.05 for 200 and
1000 mM versus control cells) and insulin-treated cells
(P!0.05 for 200 and P!0.01 for 1000 mM versus cells
treated with insulin alone). The percentage of glucose
converted to lactate was not affected by either VC or
insulin treatment (data not shown).
Finally, the amount of glycerol released (Fig. 1C), as a
lipolysis marker, showed a VC-reduced pattern that was
nearly the same as that shown by lactate that was
produced, presenting significant differences in non-
insulin-treated cells at VC concentrations of 200 and
1000 mM (P!0.01 for both versus control cells) and in
insulin-treated cells at 50 (P!0.01), 200 (P!0.05), and
1000 mM (P!0.01) compared with the cells treated
with insulin alone.Figure 2 Effects of vitamin C (log (5–1000 mM)) in the absence
(white circles) or presence (black triangles) of 1.6 nM insulin on
(A) leptin, (B) adiponectin, and (C) visfatin secretion in isolated rat
adipocytes over 72 h in culture. Data (nR4, median and
interquartile range). aP!0.05 and bP!0.01 versus control cells
(with or without insulin treatment). *P!0.05, control versus
controlCinsulin cells. VC, vitamin C; Ins, insulin; NS, not
significant.Adipokine secretion
The role of VC in the secretion of different adipokines
by the adipocytes was also evaluated (Fig. 2). In first
instance, leptin secretion into the culture medium after
72 h was detected (Fig. 2A), and significant effects ofJournal of Molecular Endocrinology (2010) 45, 33–43insulin and VC treatment on its secretion were observed
(P!0.001). Increasing concentrations of VC induced a
dose-dependent inhibition on both basal (P!0.05 for
200 and 1000 mM versus control cells) and insulin-
stimulated leptin secretion (P!0.01 for 200 and
1000 mM versus insulin-treated cells). Insulin treatment
effectively induced leptin secretion with respect to the
control cells (P!0.05). In contrast, in the case of
adiponectin, despite the fact that a significant global
effect was detected (P!0.05), no differences among
experimental groups were observed (Fig. 2B). Finally,
concerning visfatin secretion into the culture medium,
no significant differences were detected in the
VC-treated cells (Fig. 2C).
Furthermore, the leptin secretion into the culture
medium presented positive and significant correlations
with the glucose uptake of the VC-treated adipocytes
in both untreated (rZ0.566, P!0.01) and insulin-
stimulated cells (rZ0.797, P!0.001; Fig. 3A and B
respectively), and also with glycerol release in both
untreated (rZ0.787, P!0.001) and insulin-stimulated
cells (rZ0.791, P!0.001; Fig. 3C and D respectively).www.endocrinology-journals.org
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Figure 3 Analysis of the association between leptin secretion and (A) basal glucose uptake,
(B) insulin-stimulated glucose uptake, and the amount of glycerol released in the (C) absence
and (D) presence of insulin. All the VC concentrations (0–1000 mM) are included. Graph
symbols represent: open circles, 0 mM; closed circles, 5 mM; diamonds, 10 mM; squares,
50 mM; triangles, 200 mM; and inverted triangles, 1000 mM VC concentrations. r, Spearman’s
correlation coefficient.
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and obesity-related genes
For these analyses, 200 mM VC and control samples
were chosen for total mRNA extraction followed by
gene expression of the three selected adipokines. This
concentration was considered physiological according
to Levine et al. (1996). Leptin mRNA expression
presented no significant differences in insulin- or
VC-treated cells (Fig. 4A), but a correlation with the
glucose uptake in insulin-stimulated cells (rZ0.810,
P!0.05) was detected. Regarding the other assayed
adipokines, no statistically significant differences were
observed in adiponectin mRNA expression (Fig. 4B),
but a slightly significant effect of the treatments on
visfatin gene expression was detected (Fig. 4C),
probably induced by the elevated mRNA expression
found in VCCinsulin-treated adipocytes.
Gene expression of several other genes involved
in obesity-related mechanism was also examined.
Important and significant modifications were observed
in the Gpdh mRNA expression (P!0.05), induced
mainly by a drastic inhibition observed in the VCC
insulin-treated adipocytes (Fig. 5A). The Irs3 gene
expression (Fig. 5B) was not significantly modified bywww.endocrinology-journals.orginsulin or VC treatment. Finally, the Cdkn1a and Casp8
mRNA expressions presented significant modifications
(P!0.05 for both), mainly due to the observed
inducing effects of the VC treatment (Fig. 5D and E).ROS production
Intracellular and extracellular ROS concentrations
were measured after the 72-h treatment. Marked effects
(P!0.05) were detected on the intracellular ROS
concentration of the isolated adipocytes, mainly due
to the inhibition observed in insulin-treated cells
(Fig. 6A). On the other hand, the extracellular ROS
levels also presented reductions (P!0.05) induced
by VC incubation in both insulin-untreated and insulin-
treated cells (Fig. 6B).Discussion
Available data show inconclusive evidences regarding
possible relationships between antioxidant treatments
and obesity prevention or treatment mechanisms
(Valdecantos et al. 2009). Research with antioxidants,Journal of Molecular Endocrinology (2010) 45, 33–43
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Figure 4 Effects of vitamin C (200 mM) in the absence (white
boxes) or presence (grey boxes) of 1.6 nM insulin on (A) leptin,
(B) adiponectin, and (C) visfatin mRNA expressions in isolated
rat adipocytes over 72 h in culture. Data (nR4, median and
interquartile range). VC, vitamin C; Ins, insulin; NS, not significant.
D F GARCIA-DIAZ and others . Vitamin C effects on primary adipocytes38which are labile products, could have discrepant
outcomes concerning metabolic changes due to
experimental conditions. However, in humans, inverse
associations between VC plasma levels and body massJournal of Molecular Endocrinology (2010) 45, 33–43index ( Johnston 2005), waist–hip ratio (Canoy et al.
2005), and cardiovascular disease risk were observed
(Kurl et al. 2002). Moreover, a VC supplementation
induced some beneficial effects on glucose and
lipid metabolism in type 2 diabetic patients (Paolisso
et al. 1995).
In animal studies, it was observed that VC supple-
mentation induced insulin resistance improvement in
hyperglycemic ob/ob mice (Abdel-Wahab et al. 2002),
and decreased body weight gain in guinea pigs
(Sorensen et al. 1974). Studies by our research group
have found a high-fat diet-induced adiposity reduction
by VC supplementation in rats (Campion et al. 2006,
Garcia-Diaz et al. 2007) and modifications in adipocyte
catecholamine-induced lipolysis (Garcia-Diaz et al.
2009). In vitro studies have reported controversial VC
effects on adipocyte differentiation (Ono et al. 1990,
Krieger-Brauer & Kather 1995, Galinier et al. 2006).
In the present study, in vitro effects of VC incubation
on epididymal rat adipocyte metabolism and secretory
functions were evaluated. The glucose uptake inhi-
bition observed in adipocytes without insulin
treatment, and especially in adipocytes under insulin
treatment, could be partially explained by the fact that
dehydroascorbic acid (DHA; the oxidized form of VC
that is transported inside cells) possibly competes with
glucose for GLUT1 (SLC2A1) and GLUT3 (SLC2A3;
Arrigoni & De Tullio 2002), and for GLUT4 (SLC2A4;
Vera et al. 1993) transporters respectively. However, it
was reported previously that in primary cultures of rat
hippocampal neurons, VC accumulation inhibited the
glucose transport inside the cytoplasm independently
of this competition (Patel et al. 2001). The lactate
production inhibition by VC is in agreement with a
study that described a lactic acid plasma concentration
decrease in rats with streptozotocin-induced diabetes by
a VC/E treatment (Ruperez et al. 2008). On the other
hand, no statistical effects of VC were observed on the
percentage of glucose carbon released as lactate,
suggesting that VC did not participate in the aerobic/
anaerobic metabolism of rat adipocytes over a 72-h
culture treatment. Finally, the results showed no
glycerol modulation release by insulin. Although the
antilipolytic properties of this molecule are well known
(Elks & Manganiello 1985), the present data are in
agreement with the data reported by Perez-Matute et al.
(2007), indicating the lack of lipolysis modulation by
insulin in this experimental model. Despite this, the
lower glycerol release induced by VC may indicate
inhibited fat utilization in both insulin-treated and
non-treated adipocytes. It has been described that rats
fed with high-fat diet with VC supplementation
presented a decreased isoproterenol-induced lipolysis
compared with the rats fed with high-fat diet alone
(Garcia-Diaz et al. 2009).www.endocrinology-journals.org
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Figure 5 Effects of vitamin C (200 mM) in the absence (white boxes) or presence (grey boxes)
of 1.6 nM insulin on mRNA expression of several genes involved in (A) adipocyte
differentiation (Gpdh), (B) insulin signaling (Irs3 ), (C) cell cycle (Cdkn1a), and (D) apoptosis
(Casp8) in isolated rat adipocytes over 72 h in culture. Data (nR4, median and interquartile
range). VC, vitamin C; Ins, insulin; *P!0.05; **P!0.01; NS, not significant.
Vitamin C effects on primary adipocytes . D F GARCIA-DIAZ and others 39Regarding the secretion and expression of some
adipokines, this study has demonstrated an important
inhibitory effect of VC on leptin secretion, which is in
agreement with the previously reported reducing
effects on leptin circulatory levels of a diet with VC
supplementation given to high-fat diet-fed rats for
56 days (Garcia-Diaz et al. 2007). In that work, the
observed reduction in leptin secretion was accom-
panied by a decrease in body weight and adiposity.
However, the results of the present study suggest that
the leptin secretion inhibition was mainly due to
specific effects of the VC treatment over the adipocytes
and not due to mass-reducing effects on the leptin
secretor tissue. In another study, it was reported that the
leptin expression and secretion in cultured rat adipo-
cytes were decreased by glucose uptake inhibition
(Mueller et al. 1998). In the present study, the positive
correlation between leptin secretion and glucose
uptake observed in both insulin-treated and non-
treated cells suggests at first glance that the glucose
uptake inhibition by VC itself could be determining the
leptin secretion. In this context, previous studies
indicated that glucose utilization stimulates leptin
production by driving the glucose metabolism to
oxidation or lipogenesis, rather than anaerobic lactate
production (Mueller et al. 2000). Moreover, leptinwww.endocrinology-journals.orgsecretion presented significant positive associations
with glycerol release. This could be explained by
reports describing that leptin directly inhibits lipogen-
esis (Ramsay 2003) and stimulates lipolysis in adipo-
cytes (Fruhbeck et al. 1997). This feature could also in
part explain the lower glycerol release occurring in the
VC-incubated adipocytes. The fact that insulin induced
no higher leptin gene expression could be explained by
possible mRNA expression fluctuations during culture.
Therefore, the elevated leptin secretion observed in
insulin-treated cells could be due to an induced gene
expression that decreased time-dependently, which was
undetected at the end of the treatment. It was described
that insulin-treated primary culture epididymal adipo-
cytes produced more leptin during the first 2 h of
in vitro incubations (Barr et al. 1997). Also, an acute
significant increase in leptin secretion after a 2-h
100 nM insulin treatment, without changes in its gene
expression (Bradley & Cheatham 1999), was observed.
Moreover, it was described that biosynthetic release
rates of leptin correlate with tissue leptin content and
adiposity, but not with leptin mRNA levels in humans
(Lee et al. 2007a). Finally, the lack of effects observed on
the leptin mRNA expression by VC could be due to the
well-known ascorbic acid instability (Feng et al. 1977),
and also could be due to the lack of insulin effects, sinceJournal of Molecular Endocrinology (2010) 45, 33–43
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Figure 6 Effects of vitamin C (200 mM) in the absence or presence
of 1.6 nM insulin on intracellular (A) and extracellular (B) ROS
formation in isolated rat adipocytes over 72 h in culture. Data are
expressed in percentage (nZ3, meanGS.E.M). VC, vitamin C;
Ins, insulin.
D F GARCIA-DIAZ and others . Vitamin C effects on primary adipocytes40the most dramatic inhibitory effects of VC were
observed on insulin-induced leptin secretion. Further-
more, no data evidencing a possible intracellular leptin
accumulation by VC have been reported previously. In
any case, mRNA levels do not always correlate with the
given protein product, perhaps by post-transcriptional
regulation mechanisms (Lackner & Bahler 2008). In
fact, it is known that both feeding and insulin
treatments increase leptin translation (Lee et al. 2007b).
Regarding the mRNA expression analysis of other
obesity-related genes, the data suggest that VC treat-
ment could possibly modify some mechanisms related
to adipocyte differentiation, insulin resistance, inflam-
mation, and apoptosis. In the present study, a lowering
effect of VCCinsulin co-treatment on Gpdh mRNA
expression was observed. The available literature
reported a reduced GPDH activity in mature adipocytes
exposed to VC treatment (Hasegawa et al. 2002) and
differentiation inhibition, and consequently, reduced
GPDH activity in 3T3-L1 cells (Krieger-Brauer & Kather
1995). On the other hand, it is known that insulin isJournal of Molecular Endocrinology (2010) 45, 33–43necessary for triglyceride accumulation in preadipo-
cytes (Ntambi & Young-Cheul 2000). In fact, the
utilization of insulin for differentiation induction of
different preadipocytes cell lines is common (Ailhaud
1997). However, the treated adipocytes in this study
were mature cells isolated directly from WAT that did
not present important differentiation machinery
activity. This contradicts the lipolytic properties
described for VC (Hasegawa et al. 2002), but this
could be explained by an extra down-regulation of the
lipogenic pathways by VC treatment.
It has been observed that VC induced a slight
decrease in Irs3 mRNA expression in subcutaneous and
retroperitoneal fat pads of high-fat VC-supplemented
diet-fed rats with respect to the high-fat diet-alone-fed
obese rats (Garcia-Diaz et al. 2007). This slight mRNA
inhibition was also observed in the current study,
especially in cells under insulin treatment, suggesting
a direct relationship between VC and insulin resist-
ance/sensitivity pathways. It has been described earlier
that Irs3 overexpression induces higher translocation of
GLUT4 proteins to the membranes of rat adipose
cells, and also that mutant and non-functional IRS3
inhibits insulin action (Zhou et al. 1999). Consequently,
down-regulation of this gene could have contributed to
the observed glucose uptake VC-mediated inhibition.
However, some insulin sensitivity improvement effects
of a VC supplementation in high-fat diet-fed rats have
been described previously (Garcia-Diaz et al. 2009).
Therefore, these systemic insulin-sensitizing effects of
VC could be driven through other mechanisms rather
than through IRS3 modulation in adipocytes.
The Cdkn1a and Casp8 mRNA overexpression
observed in VC-treated adipocytes could indicate an
induced cell apoptosis (Hershenson 2004, Baumgartner
et al. 2007). These results are in agreement with the data
reported by Senen et al. (2002), who described how VC
injections in WAT deposits of rats decrease adipocyte
cell number. Despite this evidence, no effect of 200 mM
VC treatment on cell integrity/viability has been
observed, suggesting that the expression of these
genes was not directly related to cell death. Further-
more, in a study by our research group (Boque et al.
2009), a reduced mRNA expression of Cdkn1a and
p57 in subcutaneous WAT of rats fed with a high-fat diet
with respect to the controls was observed, suggesting
that this process could lead to higher adipose cell
proliferation. It was also observed that a VC dietary
supplementation induced slightly, but not significantly,
the Cdkn1a and p57 gene expressions with respect to a
high-fat-alone-fed group, which is in agreement with
the data reported in the present work.
It has been described that oxidative stress in
excessively accumulated adipose tissue is an important
trigger for the onset of obesity-related metabolic
syndrome features (Furukawa et al. 2004). Some studieswww.endocrinology-journals.org
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antioxidant vitamin (Perticone et al. 2001, Arrigoni &
De Tullio 2002). Besides, it has been observed that an
induced oxidative stress decreased GLUT4 expression
by impairing the protein binding to its promoter,
reducing glucose uptake (Pessler et al. 2001). On the
other hand, another study described that a ROS
production pathway stimulation is related to higher
GLUT1 transcription (Kao & Fong 2008). It is known
that the oxidized form of VC (DHA) is preferentially
transported by GLUT1 (Vera et al. 1993), suggesting
that VC could also induce the glucose uptake inhibition
observed due to its ROS-scavenging properties.
Therefore, the present results suggest that VC treat-
ment could be involved in ROS formation, indicating
that this inhibition could be implicated in some of the
metabolic effects described earlier.
Taking all these into account, even though leptin is a
recognized insulin-sensitizing agent (Dyck 2009), the
inhibited secretion of this adipokine induced by VC
counteracts the possible insulin improvement proper-
ties of this molecule. However, other previously
observed effects of this vitamin, such as inhibition of
the lipolytic rate (Garcia-Diaz et al. 2009) and oxidative
stress inhibition (Vincent et al. 2009), could be
associated with this possible beneficial effect, both of
which are in agreement with the present results.
In summary, VC inhibited some glucose and lipid
metabolism indicators, and also reduced the secretion
of leptin and modified the expression of some
important obesity-related proteins in primary culture
rat adipocytes. The glucose uptake decrease could be
due to VC–glucose transport competition, a fact that
possibly leads to leptin secretion inhibition, which in
turn could drive the observed lipolysis inhibition. Also,
the effects of VC on ROS modulations could be involved
in glucose and lipid metabolism regulation. The
possible insulin-sensitizing properties of VC could
also be attributed to other systemic effects rather than
to direct inhibitory effects on leptin secretion in
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